Chemfab Alkalis Share Price
321.45+0.00 (-3.08%)
-36.94% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SOLARINDSNSE
PIDILITINDNSE
SRFNSE
FLUOROCHEMNSE
GODREJINDNSE
AETHERNSE
DEEPAKNTRNSE
DEEPAKFERTNSE
FINEORGNSE
CHEMFABNSE
Chemfab Alkalis Share Price
321.45+0.00 (-3.08%)
-36.94% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 11% | -2% | -7% |
| - | - | - | 51% |
| - | 15% | -5% | -37% |
| 6% | 7% | 1% | -1% |
Peer Comparison
Symbol
SOLARINDS
PIDILITIND
SRF
FLUOROCHEM
NAVINFLUOR
GODREJIND
AETHER
DEEPAKNTR
DEEPAKFERT
FINEORG
CHEMFAB
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 18,649 | ₹170574 Cr | 75.36 | 68.18 | 283.5 | ₹1678 Cr |
| 1,584.9 | ₹160623 Cr | 59.84 | 6.03 | 30.24 | ₹2449 Cr |
| 2,524.3 | ₹74490 Cr | 32.63 | 17.18 | 106.98 | ₹1835 Cr |
| 4,957 | ₹54764 Cr | 80.65 | 22.09 | 97.5 | ₹577 Cr |
| 10,203 | ₹52333 Cr | 57.47 | 52.48 | 208.91 | ₹664 Cr |
| 1,090.35 | ₹37074 Cr | 24.84 | 16.61 | 60.64 | ₹1241 Cr |
| 1,678.5 | ₹22515 Cr | 90.34 | 5.12 | 24.71 | ₹219 Cr |
| 1,547.8 | ₹21197 Cr | 19.96 | 29.15 | 96.58 | ₹551 Cr |
| 1,438 | ₹18369 Cr | 15.77 | 31.19 | 125.33 | ₹737 Cr |
| 5,495 | ₹16731 Cr | 34.73 | 49.62 | 176.69 | ₹417 Cr |
| 316.05 | ₹474 Cr | — | -1.47 | 21.39 | -₹3 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹76 Cr | ₹73 Cr | ₹75 Cr | ₹68 Cr | ₹77 Cr | ₹92 Cr | ₹92 Cr | ₹84 Cr | ₹82 Cr | ₹77 Cr | ₹82 Cr | ₹86 Cr | ₹80 Cr | ₹79 Cr | ₹73 Cr | ₹84 Cr | ₹76 Cr | ₹98 Cr | ₹88 Cr | ₹78 Cr | ₹59 Cr | ₹47 Cr | ₹51 Cr | ₹46 Cr | ₹43 Cr | ₹40 Cr | ₹41 Cr | ₹51 Cr |
| ₹38 L | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹3 Cr | ₹60 L | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹66 L | ₹3 Cr | ₹54 L | ₹39 L | ₹2 Cr | ₹58 L | ₹28 L | ₹27 L | ₹29 L | ₹2 Cr | ₹28 L |
| ₹76 Cr | ₹75 Cr | ₹78 Cr | ₹71 Cr | ₹78 Cr | ₹93 Cr | ₹94 Cr | ₹86 Cr | ₹82 Cr | ₹79 Cr | ₹84 Cr | ₹88 Cr | ₹81 Cr | ₹83 Cr | ₹75 Cr | ₹86 Cr | ₹77 Cr | ₹99 Cr | ₹91 Cr | ₹78 Cr | ₹59 Cr | ₹49 Cr | ₹52 Cr | ₹47 Cr | ₹43 Cr | ₹41 Cr | ₹43 Cr | ₹51 Cr |
| ₹76 Cr | ₹71 Cr | ₹74 Cr | ₹74 Cr | ₹78 Cr | ₹87 Cr | ₹90 Cr | ₹81 Cr | ₹81 Cr | ₹76 Cr | ₹76 Cr | ₹77 Cr | ₹74 Cr | ₹69 Cr | ₹54 Cr | ₹65 Cr | ₹56 Cr | ₹69 Cr | ₹75 Cr | ₹61 Cr | ₹58 Cr | ₹44 Cr | ₹53 Cr | ₹45 Cr | ₹42 Cr | ₹38 Cr | ₹41 Cr | ₹43 Cr |
| ₹7 Cr | ₹12 Cr | ₹11 Cr | ₹5 Cr | ₹7 Cr | ₹13 Cr | ₹15 Cr | ₹14 Cr | ₹11 Cr | ₹11 Cr | ₹14 Cr | ₹17 Cr | ₹12 Cr | ₹19 Cr | ₹26 Cr | ₹27 Cr | ₹27 Cr | ₹36 Cr | ₹22 Cr | ₹23 Cr | ₹7 Cr | ₹10 Cr | ₹4 Cr | ₹6 Cr | ₹6 Cr | ₹8 Cr | ₹9 Cr | ₹15 Cr |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹94 L | ₹41 L | ₹43 L | ₹6 L | ₹5 L | ₹4 L | ₹5 L | ₹4 L | ₹12 L | ₹7 L | ₹9 L | ₹33 L | ₹52 L | ₹56 L | ₹56 L | ₹56 L | ₹77 L | ₹73 L | ₹75 L |
| -₹3 Cr | ₹2 Cr | ₹1 Cr | -₹5 Cr | -₹1 Cr | ₹5 Cr | -₹7 Cr | ₹4 Cr | ₹73 L | ₹3 Cr | ₹8 Cr | ₹11 Cr | ₹7 Cr | ₹14 Cr | ₹21 Cr | ₹21 Cr | ₹18 Cr | ₹30 Cr | ₹16 Cr | ₹17 Cr | ₹1 Cr | ₹4 Cr | -₹2 Cr | ₹62 L | ₹84 L | ₹2 Cr | -₹6 Cr | ₹7 Cr |
| -₹2 Cr | ₹6 Cr | ₹49 L | -₹4 Cr | -₹2 Cr | ₹3 Cr | -₹9 Cr | ₹2 Cr | -₹54 L | ₹90 L | ₹5 Cr | ₹7 Cr | ₹4 Cr | ₹10 Cr | ₹15 Cr | ₹15 Cr | ₹13 Cr | ₹21 Cr | ₹13 Cr | ₹12 Cr | ₹82 L | ₹3 Cr | -₹12 Cr | ₹1 Cr | ₹65 L | ₹2 Cr | ₹2 Cr | ₹6 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — |
| ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
| ₹0 | ₹28 L | ₹2 Cr | ₹1 Cr | ₹94 L | ₹57 L | ₹37 L |
| ₹361 Cr | ₹365 Cr | ₹371 Cr | ₹346 Cr | ₹283 Cr | ₹253 Cr | ₹261 Cr |
| ₹361 Cr | ₹365 Cr | ₹371 Cr | ₹346 Cr | ₹283 Cr | ₹253 Cr | ₹261 Cr |
| ₹375 Cr | ₹380 Cr | ₹387 Cr | ₹361 Cr | ₹298 Cr | ₹267 Cr | ₹276 Cr |
| ₹70 Cr | ₹64 Cr | ₹16 Cr | ₹0 | ₹0 | ₹23 Cr | ₹22 Cr |
| ₹11 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| -₹21 Cr | -₹23 Cr | -₹26 Cr | -₹31 Cr | -₹40 Cr | -₹43 Cr | -₹52 Cr |
| ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr |
| ₹9 Cr | ₹36 Cr | ₹31 Cr | ₹31 Cr | ₹30 Cr | ₹30 Cr | ₹14 Cr |
| ₹72 Cr | ₹80 Cr | ₹25 Cr | ₹3 Cr | -₹6 Cr | ₹13 Cr | -₹15 Cr |
| — | — | — | — | — | — | — |
| ₹31 Cr | ₹32 Cr | ₹27 Cr | ₹28 Cr | ₹20 Cr | ₹18 Cr | ₹17 Cr |
| ₹57 Cr | ₹35 Cr | ₹60 Cr | ₹13 Cr | ₹19 Cr | ₹19 Cr | ₹15 Cr |
| ₹23 Cr | ₹2 Cr | ₹0 | ₹63,000 | ₹7 Cr | ₹42 L | ₹14 Cr |
| ₹34 Cr | ₹34 Cr | ₹35 Cr | ₹27 Cr | ₹12 Cr | ₹4 Cr | ₹30 Cr |
| ₹144 Cr | ₹103 Cr | ₹122 Cr | ₹68 Cr | ₹58 Cr | ₹42 Cr | ₹76 Cr |
| ₹592 Cr | ₹563 Cr | ₹535 Cr | ₹433 Cr | ₹349 Cr | ₹322 Cr | ₹337 Cr |
| ₹12 Cr | ₹12 Cr | ₹203 Cr | ₹2 Cr | ₹3 Cr | ₹17 L | ₹84 L |
| ₹123 Cr | ₹83 Cr | ₹18 Cr | ₹63,000 | ₹7 Cr | ₹31 Cr | ₹42 Cr |
| — | — | — | — | — | — | — |
| ₹513 Cr | ₹468 Cr | ₹363 Cr | ₹289 Cr | ₹277 Cr | ₹274 Cr | ₹286 Cr |
| ₹126 Cr | ₹151 Cr | ₹116 Cr | ₹97 Cr | ₹83 Cr | ₹72 Cr | ₹91 Cr |
| ₹387 Cr | ₹317 Cr | ₹247 Cr | ₹192 Cr | ₹194 Cr | ₹202 Cr | ₹195 Cr |
| ₹31 Cr | ₹36 Cr | ₹74 Cr | ₹31 Cr | ₹8 Cr | ₹3 Cr | ₹35 Cr |
| ₹8 L | ₹10 L | ₹12 L | ₹7 L | ₹5 L | ₹3 L | ₹2 L |
| ₹8 L | ₹10 L | ₹12 L | ₹7 L | ₹5 L | ₹3 L | ₹2 L |
| ₹16 Cr | ₹60 Cr | ₹81 Cr | ₹63 Cr | ₹47 Cr | ₹40 Cr | ₹28 Cr |
| ₹4 L | ₹23 L | ₹2 Cr | ₹47 L | ₹45 L | ₹43 L | ₹60 L |
| ₹434 Cr | ₹413 Cr | ₹404 Cr | ₹286 Cr | ₹250 Cr | ₹246 Cr | ₹259 Cr |
| — | — | — | — | — | — | — |
| ₹13 Cr | ₹16 Cr | ₹5 Cr | ₹68 Cr | ₹31 Cr | ₹24 Cr | ₹67 L |
| ₹26 Cr | ₹27 Cr | ₹16 Cr | ₹17 Cr | ₹12 Cr | ₹9 Cr | ₹9 Cr |
| ₹24 Cr | ₹21 Cr | ₹21 Cr | ₹22 Cr | ₹21 Cr | ₹15 Cr | ₹10 Cr |
| ₹92 L | ₹5 Cr | ₹25 Cr | ₹4 Cr | ₹8 Cr | ₹3 Cr | ₹3 Cr |
| ₹66 L | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹17 Cr | ₹14 Cr |
| ₹56 Cr | ₹57 Cr | ₹56 Cr | ₹28 Cr | ₹15 Cr | ₹8 Cr | ₹43 Cr |
| ₹121 Cr | ₹127 Cr | ₹126 Cr | ₹141 Cr | ₹89 Cr | ₹76 Cr | ₹78 Cr |
| -₹23 Cr | ₹24 Cr | ₹4 Cr | ₹73 Cr | ₹32 Cr | ₹34 Cr | ₹2 Cr |
| ₹592 Cr | ₹563 Cr | ₹535 Cr | ₹433 Cr | ₹349 Cr | ₹322 Cr | ₹337 Cr |
| ₹261 | ₹264 | ₹271 | ₹254 | ₹210 | ₹190 | ₹197 |
| ₹261 | ₹264 | ₹271 | ₹254 | ₹210 | ₹190 | ₹197 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| -₹20 L | -₹31 L | ₹39 Cr | ₹89 Cr | ₹39 Cr | ₹2 Cr | ₹27 Cr |
| ₹32 Cr | ₹49 Cr | ₹17 Cr | ₹22 Cr | ₹24 Cr | ₹27 Cr | ₹34 Cr |
| ₹7 Cr | -₹2 Cr | -₹15 Cr | -₹4 Cr | -₹2 Cr | ₹8 Cr | ₹42 L |
| ₹39 Cr | ₹46 Cr | ₹41 Cr | ₹107 Cr | ₹61 Cr | ₹37 Cr | ₹61 Cr |
| ₹38 Cr | ₹40 Cr | ₹31 Cr | ₹93 Cr | ₹55 Cr | ₹45 Cr | ₹54 Cr |
| -₹81 Cr | -₹86 Cr | -₹110 Cr | -₹48 Cr | -₹21 Cr | -₹6 Cr | -₹58 Cr |
| ₹31 Cr | ₹59 Cr | ₹16 Cr | -₹9 Cr | -₹25 Cr | -₹16 Cr | ₹3 Cr |
| -₹12 Cr | ₹13 Cr | -₹62 Cr | ₹36 Cr | ₹9 Cr | ₹23 Cr | -₹1 Cr |
| ₹19 Cr | ₹7 Cr | ₹69 Cr | ₹33 Cr | ₹23 Cr | ₹4 L | ₹1 Cr |
| ₹8 Cr | ₹19 Cr | ₹7 Cr | ₹69 Cr | ₹33 Cr | ₹23 Cr | ₹4 L |
Fundamental Ratios
Consolidated
Standalone

No results found
Chemfab Alkalis Share Price
321.45+0.00 (-3.08%)
-36.94% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 1
Bearish signals: 4 out of 9 oscillators
RSI
50.96Neutral
STOCH %K
37.73Neutral
MACD Level(12,26)
-0.61Sell
Ultimate Oscillator
41.64Sell
Aroon Oscillator
-56.00Sell
BOP
-0.20Sell
CCI
84.03Neutral
Williams %R
-62.27Neutral
Momentum
23.65Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 5
Bearish signals: 4 out of 9 moving averages
EMA 9
320.36Buy
SMA 9
318.95Buy
EMA 21
318.22Buy
SMA 21
310.65Buy
EMA 50
328.53Sell
SMA 50
330.69Sell
EMA 200
395.08Sell
SMA 200
369.25Sell
WMA 20
315.46Buy
Pivot
Pivot
Classic
Resistance 5
406.35
Resistance 4
388.55
Resistance 3
370.75
Resistance 2
352.95
Resistance 1
342.30
Pivot
335.15
Support 1
324.50
Support 2
317.35
Support 3
299.55
Support 4
281.75
Support 5
263.95
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Chemfab Alkalis Share Price
321.45+0.00 (-3.08%)
-36.94% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 72.13% | 72.13% | 72.13% | 72.13% | 72.18% | 72.18% |
| 0.04% | 0.04% | 0.04% | 0.08% | 0.00% | 0.01% |
| 0.00% | 0.00% | 0.03% | 0.15% | 0.20% | 0.20% |
| 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% |
| 27.76% | 27.76% | 27.73% | 27.57% | 27.55% | 27.54% |
Bulk & block deals
Name
Multiplier Share & Stock Advisors Private Limited
Multiplier Share & Stock Advisors Private Limited
Mansi Shares & Stock Advisors Pvt Ltd
Mansi Shares & Stock Advisors Pvt Ltd
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 13 Sep 2022 | Purchase | 2.59 Cr | ₹431.85 | 60.04 K | Bulk | 0.417728 | NSE |
| 13 Sep 2022 | Sell | 3.85 Cr | ₹432.20 | 89.07 K | Bulk | 0.61968 | NSE |
| 06 Sep 2022 | Sell | 3.04 Cr | ₹352.22 | 86.44 K | Bulk | 0.601341 | NSE |
| 06 Sep 2022 | Purchase | 2.32 Cr | ₹348.21 | 66.49 K | Bulk | 0.462553 | NSE |
Insider trading & SAST
Client name
S Prasath
Vaithamanithi Mudumbai Srinivasan
K Venugopal
S Anand
Vaithamanithi Mudumbai Srinivasan
Vaithamanithi Mudumbai Srinivasan
Vaithamanithi Mudumbai Srinivasan
Vaithamanithi Mudumbai Srinivasan (Revised)
V.m.srinivasan
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05 Feb 2025 | Designated Person | Acquisition | 0.097468 | 0.28 | 13.70 L | ₹97.83 | 14 K | 31 Jan 2025 | ESOP | 40,100 | Insider Trading | — | Equity Shares |
| 05 Feb 2025 | Designated Person | Acquisition | 0.247151 | 1.8 | 34.73 L | ₹97.83 | 35.50 K | 31 Jan 2025 | ESOP | 2,59,656 | Insider Trading | — | Equity Shares |
| 20 Nov 2024 | Designated Person | Disposal | 0.009099 | 0.06 | 12.63 L | ₹971.54 | 1.30 K | 15 Nov 2024 - 19 Nov 2024 | Market Sale | 8,700 | Insider Trading | — | Equity Shares |
| 19 Sep 2024 | Employee | Disposal | 0.0063 | 0.12 | 8.31 L | ₹923.26 | 900 | 17 Sep 2024 - 18 Sep 2024 | Market Sale | 16,271 | Insider Trading | — | Equity Shares |
| 23 May 2024 | KMP | Acquisition | 0.249533 | 1.57 | 34.73 L | ₹97.83 | 35.50 K | 23 May 2024 | ESOP | 2,24,356 | Insider Trading | — | Equity Shares |
| 20 May 2023 | KMP | Acquisition | 0.073982 | 1.33 | 10.27 L | ₹97.83 | 10.50 K | 18 May 2023 | ESOP | 1,88,856 | Insider Trading | — | Equity Shares |
| 23 Mar 2023 | KMP | Disposal | 0.17628 | 1.26 | 57.92 L | ₹231.68 | 25 K | 23 Mar 2023 | Market Sale | 1,78,356 | Insider Trading | — | Equity Shares |
| 23 Mar 2023 | KMP | Acquisition | 0.17628 | 1.43 | 24.46 L | ₹97.83 | 25 K | 07 Feb 2023 | ESOP | 2,03,356 | Insider Trading | — | Equity Shares |
| 03 Feb 2022 | KMP | Acquisition | 0.252319 | 1.26 | 34.73 L | ₹97.83 | 35.50 K | 31 Jan 2022 | ESOP | 1,78,356 | Insider Trading | — | Equity Shares |
Chemfab Alkalis Share Price
321.45+0.00 (-3.08%)
-36.94% past 1 Year
Chemfab Alkalis Ltd (CCAL) is one of the first major chemical organisations in India to introduce and implement innovative technologies successfully and stay at the forefront of the industry. With
Corporate Actions
Date
Type
Details
Company details
Chemfab Alkalis Share Price
321.45+0.00 (-3.08%)
-36.94% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Chemfab Alkalis Share Price
321.45+0.00 (-3.08%)
-36.94% past 1 Year
News
1 of 20
ResultCHEMFAB29 Jul 2026
Chemfab Alkalis has reported its Q1 performance with a mixed operating picture, marked by a year-on-year decline in EBITDA but an improvement in operating profitability margins. The company posted Q1 EBITDA of Rs 10.10 crores, compared with Rs 11.30 crores in the same quarter last year, indicating a contraction in absolute operating earnings on a yearly basis. This points to either softer revenue, higher operating costs, or a combination of both, though specific revenue and PAT figures are not available in the provided context and therefore are not discussed.
Despite the decline in EBITDA, Chemfab Alkalis delivered a notable improvement in operating efficiency, as reflected in the Q1 EBITDA margin. The EBITDA margin for the quarter stood at 13.85 percent versus 12.34 percent in the year-ago period. This year-on-year margin expansion suggests better cost management, pricing, or product mix optimization, allowing the company to generate higher operating profitability per unit of revenue even as total EBITDA fell. Without explicit data on revenue growth or decline, the margin improvement implies that the revenue base may have moderated or stayed relatively stable while costs were controlled more effectively than in the prior year, or that the business mix shifted towards higher-margin products or contracts.
In the absence of details on Q1 revenue, PAT, net margin, or management commentary, the earnings assessment remains focused on EBITDA and operating margin dynamics. The combination of lower EBITDA and higher margins typically indicates that scale or volume effects weighed on overall operating profits, even as underlying operational discipline strengthened. Market reaction, consensus expectations, and guidance are not available in the given information set, so no inference is made regarding how these results compare with street forecasts or how the stock has responded in the immediate aftermath. Overall, the Q1 numbers for Chemfab Alkalis reflect an efficiency-led margin improvement offset by weaker absolute operating earnings, making the operating outcome directionally mixed.
Chemfab Alkalis reports weaker Q1 revenue performance on year-on-year basis
ResultCHEMFAB29 Jul 2026
Chemfab Alkalis has reported a decline in its Q1 revenue on a year-on-year basis, indicating a softer topline performance for the quarter. The company posted revenue of Rs 73.20 crores in the latest Q1 period, compared with Rs 91.50 crores in the corresponding quarter of the previous financial year. This represents a notable contraction in sales, suggesting demand or pricing pressures in its operating segments, or a less favourable operating environment relative to the prior year. The magnitude of the revenue decline is material in the context of quarterly performance and is likely to draw attention from both institutional and retail investors tracking the stock on NSE and BSE.
Key profitability metrics such as EBITDA, PAT and margin trends have not been disclosed in the provided context, so any assessment of operating leverage, cost control or net earnings impact cannot be made without additional verified data. Similarly, there is no information on quarter-on-quarter comparison, street expectations or consensus forecasts, making it difficult to judge whether the reported numbers are ahead of or behind market estimates. No management commentary, guidance or strategic updates have been mentioned, and there is no verifiable data on immediate stock price reaction or trading volumes post the result announcement.
Within these constraints, the primary takeaway for market participants is that Chemfab Alkalis has experienced a significant year-on-year decline in Q1 revenue from Rs 91.50 crores to Rs 73.20 crores. Investors may await detailed result disclosures, including segmental performance, margin behaviour, cost dynamics and management outlook, to form a more comprehensive view on the company’s near-term earnings trajectory and its positioning within the chemicals and alkalis space in the Indian equity markets.
Chemfab Alkalis Q1 net profit surges year-on-year on stronger performance
ResultCHEMFAB29 Jul 2026
Chemfab Alkalis reported a strong improvement in profitability for the latest Q1 period, with consolidated net profit rising to Rs 5.70 crores from Rs 2.50 crores in the corresponding quarter last year. This sharp year-on-year increase in profit indicates a materially better earnings performance compared with the prior year, reflecting either higher operating efficiency, better realisations, or an improved product mix, even though detailed revenue and EBITDA data are not available in the provided context. The expansion in profit suggests that net margins have improved meaningfully versus the same quarter of the previous financial year, as profit growth has substantially outpaced the prior base. In the absence of explicit disclosures on revenue, operating profit, or margin percentages, the focus remains on the headline net profit trajectory, which is clearly positive and points to a healthier financial position on a year-on-year basis.
Given that consensus street expectations, detailed segmental performance, and management commentary are not specified, it is not possible to benchmark these results versus market forecasts or to attribute the improvement to specific operational drivers with precision. There is also no information on quarter-on-quarter trends, debt levels, cash flows, or capacity utilisation, which limits deeper ratio or margin analysis. Nevertheless, the strong growth in consolidated net profit is a key takeaway for market participants tracking Chemfab Alkalis, as it signals improved earnings momentum compared with the same quarter a year earlier. In the absence of any data on immediate share price reaction or F&O positioning, the market impact is best viewed as company-specific and routine, important for Chemfab Alkalis shareholders but not of index-moving scale.
Chemfab Alkalis informs about newspaper advertisement
Stock NewsCHEMFAB6 Jun 2026
NULL
Chemfab Alkalis soars on investing Rs 14.91 crore in Zenataris Renewable Energy
Stock NewsCHEMFAB21 May 2026
This investment will result in a lower tariff and consequent cost savings
Chemfab Alkalis invests Rs 14.91 crore in Zenataris Renewable Energy
Stock NewsCHEMFAB20 May 2026
This investment will result in a lower tariff and consequent cost savings
Chemfab Alkalis informs about acquisition
Stock NewsCHEMFAB20 May 2026
NULL
Chemfab Alkalis Q4 EBITDA Declines to Rs 8.50 Crores, Margin at 11.40% YoY
ResultCHEMFAB13 May 2026
Chemfab Alkalis reported its Q4 financial results, showing a year-over-year decline in EBITDA. The company's EBITDA for the quarter stood at Rs 8.50 crores, down from Rs 13.30 crores in the same quarter of the previous year. EBITDA margin also contracted to 11.40% from 14.45% YoY.
The results indicate weaker profitability compared to the prior year, though specific revenue or PAT figures were not disclosed in the update. No comparisons to street expectations or management guidance were provided. Quarter-over-quarter changes remain unavailable from the given data.
Chemfab Alkalis Q4 Consolidated Net Profit Swings to Rs 50 Lakh Gain from Rs 9.20 Crore Loss YoY
ResultCHEMFAB13 May 2026
Chemfab Alkalis reported its Q4 consolidated financial results, marking a significant turnaround in profitability. The company posted a net profit of Rs 50.00 lakhs, compared to a net loss of Rs 9.20 crores in the same quarter of the previous year (YoY). This represents a substantial improvement in bottom-line performance.
On the revenue front, Q4 consolidated revenue stood at Rs 74.70 crores, reflecting a decline from Rs 92.30 crores recorded in Q4 of the prior year (YoY). The reduction in topline underscores potential challenges in sales volume or pricing pressures during the quarter, though specific factors were not detailed in the announcement.
No information was provided on EBITDA, margins, or comparisons to street expectations or consensus estimates. Management commentary or forward guidance was absent from the available data. The results highlight a resilient cost management amid softer revenue, driving the profit recovery.
Chemfab Alkalis reports Profit after tax of 1.56 Crores, in the March 2026 quarter
ResultCHEMFAB13 May 2026
NULL
Chemfab Alkalis informs about board meeting
Stock NewsCHEMFAB7 May 2026
NULL
Chemfab Alkalis submits investor presentation
Stock NewsCHEMFAB29 Jan 2026
NULL
Chemfab Alkalis Q3FY25 Results: EBITDA Falls 83% YoY to Rs 2 Cr, Margin at 2.86%.
ResultCHEMFAB28 Jan 2026
Chemfab Alkalis Ltd reported Q3FY25 results with total income at Rs 86.17 crores, up 4.4% QoQ from Rs 82.50 crores but down 1.9% YoY from Rs 87.84 crores. EBITDA declined sharply to Rs 2.00 crores from Rs 11.90 crores YoY, with EBITDA margin contracting to 2.86% from 14.23% YoY. Total expenses rose to Rs 82.53 crores, up 0.9% QoQ and 7.2% YoY from Rs 77.01 crores.
Profit before tax stood at Rs 3.64 crores, surging 398.6% QoQ from Rs 0.73 crores but down 66.4% YoY from Rs 10.83 crores. Profit after tax was Rs 1.88 crores, reversing a QoQ loss of Rs 0.53 crores (change of -454.7%) but declining 73.5% YoY from Rs 7.10 crores. Earnings per share was Rs 1.30, up from negative Rs 0.40 QoQ but down 74.0% YoY from Rs 5.00.
The results reflect pressure on operating profitability amid rising expenses, despite modest QoQ revenue growth, in the industrial chemicals sector.
Chemfab Alkalis Q3FY25 Reports Net Loss of Rs 4.44 Crores vs YoY Profit, Revenue Down.
ResultCHEMFAB28 Jan 2026
Chemfab Alkalis reported consolidated Q3 results with a **net loss of Rs 4.44 crores**, compared to a profit of Rs 1.88 crores in the year-ago quarter. Revenue declined to **Rs 68.10 crores** from Rs 83.60 crores YoY.
Conflicting data from other sources indicate varying figures: one report shows Q3FY25 revenue at Rs 86.17 crores (up 4.4% QoQ, down 1.9% YoY) and profit after tax at Rs 1.88 crores (down 73.5% YoY from Rs 7.10 crores). The primary context highlights a shift to loss and steeper revenue drop, signaling profitability pressures amid rising expenses.
Chemfab Alkalis reports Profit after tax of Rs -1.04 Crores, in the December 2025 quarter
ResultCHEMFAB28 Jan 2026
NULL
Chemfab Alkalis zooms on commissioning latest generation INEOS Electrolyser
Stock NewsCHEMFAB7 Jan 2026
The company has invested around Rs 57 crore in this project, which was funded through internal accruals
Chemfab Alkalis commissions latest generation INEOS Electrolyser
Stock NewsCHEMFAB6 Jan 2026
The company has invested around Rs 57 crore in this project, which was funded through internal accruals
Chemfab Alkalies installs new INEOS electrolyser, anticipates higher operating rates and power savings from Q4 FY26.
Stock NewsCHEMFAB6 Jan 2026
Chemfab Alkalies Ltd has installed a new INEOS electrolyser to replace 30-year-old equipment, expecting increased operating rates and power savings starting Q4 FY26. The Rs 57 crore capital expenditure was financed through internal funds.
This upgrade aligns with the company's earlier project where its wholly owned subsidiary, Chemfab Alkalis Karaikal Limited (CAKL), selected INEOS BICHLOR™ bipolar membrane electrolysers for a new 250 TPD chlor-alkali plant in Karaikal, South India, expandable to 1000 TPD. The electrolysers offer low power consumption, significant energy savings, high NaOH output, and robust construction for enhanced efficiency and safety. CEO V.M. Srinivasan highlighted focus on energy efficiency and safety in partner selection.
The installation supports improved production capacity and cost reductions, potentially boosting earnings through lower power costs and higher utilization, strengthening Chemfab's position in the chemicals sector.
Chemfab Alkalis informs about investor presentation
Stock NewsCHEMFAB1 Nov 2025
NULL
Chemfab Alkalis reports Profit after tax of 1.59 Crores, in the September 2025 quarter
ResultCHEMFAB31 Oct 2025
NULL

